Skip to content

600771.SH

广誉远

SSE · Healthcare · Drug Manufacturers - General · CN

CNY 13.24
−1.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.4B1.4B1.2B1.3B1.1B
Cost of Revenue464.1M443.7M322.2M347.4M367.2M
Gross Profit976.3M925.6M899.2M936.6M763.5M
Operating Expenses
R&D Expense36.2M38.5M38.6M31.4M29.0M
SG&A Expense
General & Admin Expense94.1M90.8M86.5M92.8M89.3M
Selling & Marketing Expense676.9M638.4M579.3M643.5M792.8M
Other Expenses
Total Operating Expenses844.4M801.8M738.2M814.9M956.8M
Cost and Expenses1.3B1.2B1.1B1.2B1.3B
Operating Income (EBIT)118.9M110.1M90.8M114.8M(273.4M)
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)111.9M103.0M80.8M100.4M(265.1M)
Income Tax Expense44.3M39.3M(2.8M)7.5M(2.1M)
Bottom Line
Net Income66.2M63.0M74.5M90.1M(250.0M)
Earnings from Cont. Ops67.5M63.7M83.6M92.9M(263.0M)
Earnings from Discont. Ops
Bottom Line Net Income66.2M63.0M74.5M90.1M(250.0M)
Per Share
Basic EPSCN¥0.14CN¥0.13CN¥0.15CN¥0.18(CN¥0.51)
Diluted EPSCN¥0.14CN¥0.13CN¥0.15CN¥0.18(CN¥0.51)
Revenue Per ShareCN¥2.94CN¥2.82CN¥2.46CN¥2.57CN¥2.31
Shares
Basic Shares Outstanding489.6M485.0M496.4M500.4M490.2M
Diluted Shares Outstanding489.6M485.0M496.4M500.4M490.2M
Profitability Metrics
EBITDA149.9M136.6M156.6M(231.6M)
D&A39.7M45.8M41.8M41.8M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026